Outstanding Investigator Award (R35)
The summary for the Outstanding Investigator Award (R35) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Outstanding Investigator Award (R35): This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research. The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to experienced investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit an application nominating an established Program Director/Principal Investigator (PD/PI) for a 7-year grant. It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research.
Federal Grant Title: | Outstanding Investigator Award (R35) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-14-267 |
Type of Funding: | Grant |
CFDA Numbers: | 93.393, 93.394, 93.395, 93.396, 93.399 |
CFDA Descriptions: | Cancer Cause and Prevention Research; Cancer Detection and Diagnosis Research; Cancer Treatment Research; Cancer Biology Research; Cancer Control |
Current Application Deadline: | Jan 7, 2015 |
Original Application Deadline: | Jan 7, 2015 |
Posted Date: | Jun 27, 2014 |
Creation Date: | Jun 27, 2014 |
Archive Date: | Feb 7, 2015 |
Total Program Funding: | |
Maximum Federal Grant Award: | $600,000 |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments
Private institutions of higher education
Small businesses
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Public and State controlled institutions of higher education
Independent school districts
Special district governments
Public housing authorities/Indian housing authorities - Additional Information on Eligibility
- Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. - Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PAR-14-267.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
- • Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- • National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer ...
- • Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Cli...
- • Early-Stage Development of Informatics Technologies for Cancer Research and Management (U0...
- • Pilot Studies in Pancreatic Cancer
- • Cancer Prevention Research Small Grant Program
- • Molecular Targets for Nutrients in Prostate Cancer Prevention
- More Grants from the National Institutes of Health
- • The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Preven...
- • Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
- • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...